Immunoglobulin E–independent Major Histocompatibility Complex–restricted T Cell Peptide Epitope–induced Late Asthmatic Reactions

Intradermal administration of short overlapping peptides derived from chain 1 of the cat allergen Fel d 1 (FC1P) that did not cross-link IgE, elicited isolated late asthmatic reactions with no visible early or late cutaneous response in 9/40 cat-allergic asthmatics. Four of the nine were human histocompatibility leukocyte antigen DR13-positive, as compared with only 1/31 nonreactors. The other five reactors expressed either DR1 or DR4. To confirm major histocompatibility complex restriction, fibroblast cell lines transfected with HLA-DR molecules were used to present FC1Ps to cat allergen-specific T cell lines derived from subjects before peptide injection. FC1P3 (peptide 28-44 of Fel d 1 chain 1) was recognized in the context of DR13 alleles (DRB1*1301, 1302) and induced specific T cell proliferation and IL-5 production. T cells from a DR1(+) responder proliferated and produced IL-5 in the presence of FC1P3 and DR1 (DRB1*0101) fibroblast cell lines, whereas T cells from a DR4(+) subject recognized FC1P2 (peptide 22-37) when presented by DRB1*0405. We conclude that short, allergen-derived peptides can directly initiate a major histocompatibility complex-restricted, T cell-dependent late asthmatic reaction, without the requirement for an early IgE/mast cell-dependent response, in sensitized asthmatic subjects.

[1]  S. Durham,et al.  Effect of cyclosporin A on the allergen-induced late asthmatic reaction. , 1997, Thorax.

[2]  A. Kay,et al.  Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma , 1998, The Lancet.

[3]  F. Simons,et al.  Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. , 1996, International immunology.

[4]  R. Jordon,et al.  ITS DEPENDENCE UPON IgE ANTIBODIES , 1976 .

[5]  R. Zinkernagel,et al.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T- cell specificities are associated with structures coded for in H-2K or H-2D; , 1975, The Journal of experimental medicine.

[6]  P. Moseley,et al.  Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. , 1987, The American review of respiratory disease.

[7]  S. Durham,et al.  Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. , 1993, American journal of respiratory cell and molecular biology.

[8]  J. Rothbard,et al.  Peptides recognized by class I restricted T cells also bind to MHC class II molecules. , 1990, International immunology.

[9]  G. Solley,et al.  The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. , 1976, The Journal of clinical investigation.

[10]  F. Hargreave,et al.  Late cutaneous allergic responses in isolated IgE-dependent reactions. , 1973, The Journal of allergy and clinical immunology.

[11]  C. Corrigan,et al.  CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. , 1990, The American review of respiratory disease.

[12]  J. Greenstein,et al.  Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Kuna,et al.  Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. , 1993, Journal of immunology.

[14]  A. Kay,et al.  Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity. , 1991, Journal of immunology.

[15]  J. Lamb,et al.  Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. , 1996, International immunology.

[16]  L. Picker,et al.  Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen , 1995, The Journal of experimental medicine.

[17]  A. Wardlaw,et al.  Eosinophils: biology and role in disease. , 1995, Advances in immunology.

[18]  C. Corrigan,et al.  T cells and eosinophils in the pathogenesis of asthma. , 1992, Immunology today.

[19]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[20]  J. Drazen,et al.  T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice , 1997, Nature Medicine.

[21]  D. Huston,et al.  Enhanced detection of human IL-5 in biological fluids utilizing murine monoclonal antibodies which delineate distinct neutralizing epitopes. , 1994, Cytokine.

[22]  S. Durham,et al.  Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. , 1990, The American review of respiratory disease.

[23]  S. Durham,et al.  Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. , 1997, Journal of immunology.

[24]  J. Morgenstern,et al.  Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes. , 1994, Molecular immunology.

[25]  J. Martin,et al.  Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats. , 1995, The Journal of clinical investigation.

[26]  K. B. Hafner,et al.  Treatment of cat allergy with T-cell reactive peptides. , 1996, American journal of respiratory and critical care medicine.

[27]  J. Bousquet,et al.  Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. , 1998, The Journal of allergy and clinical immunology.

[28]  R. Zinkernagel,et al.  H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus , 1975, The Journal of experimental medicine.

[29]  C. Corrigan,et al.  T LYMPHOCYTE ACTIVATION IN ACUTE SEVERE ASTHMA , 1988, The Lancet.